Rhythm Pharmaceuticals' high P/S ratio is alarming due to it...
Rhythm Pharmaceuticals' high P/S ratio is alarming due to its lower forecast growth compared to the industry. Future revenues may not sustain the positive sentiment, risking shareholders' investments and potential investors may pay a high premium. Investors should note the company's 2 warning signs.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000168aebb3a349fa.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment